RETRACTED: Chronic Administration of Carbamazepine Down-regulates AP-2 DNA-binding Activity and AP-2α Protein Expression in Rat Frontal Cortex
- 15 January 2007
- journal article
- retracted article
- Published by Elsevier in Biological Psychiatry
- Vol. 61 (2) , 154-161
- https://doi.org/10.1016/j.biopsych.2006.03.029
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Chronic Carbamazepine Decreases the Incorporation Rate and Turnover of Arachidonic Acid but Not Docosahexaenoic Acid in Brain Phospholipids of the Unanesthetized Rat: Relevance to Bipolar DisorderBiological Psychiatry, 2006
- Valproic acid selectively inhibits conversion of arachidonic acid to arachidonoyl–CoA by brain microsomal long-chain fatty acyl–CoA synthetases: relevance to bipolar disorderPsychopharmacology, 2005
- Review of the use of Topiramate for treatment of psychiatric disordersAnnals of General Psychiatry, 2005
- Valproic acid down‐regulates the conversion of arachidonic acid to eicosanoids via cyclooxygenase‐1 and ‐2 in rat brainJournal of Neurochemistry, 2003
- Attenuation of N-methyl-d-aspartate-mediated cytoplasmic vacuolization in primary rat hippocampal neurons by mood stabilizersNeuroscience, 2003
- Chronic lithium downregulates cyclooxygenase-2 activity and prostaglandin E2 concentration in rat brainMolecular Psychiatry, 2002
- Does Carbamazepine Have a Narrow Therapeutic Plasma Concentration Range?Therapeutic Drug Monitoring, 1998
- Sodium valproate induced alterations in monoamine levels in different regions of the rat brainNeurochemistry International, 1994
- Fluorescence ratio imaging of cyclic AMP in single cellsNature, 1991
- Receptor-mediated activation of phospholipase A2 and arachidonic acid release in signal transductionBiochemical Society Transactions, 1990